Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

44.29
Delayed Data
As of May 26
 +0.71 / +1.63%
Today’s Change
27.14
Today|||52-Week Range
80.71
-44.21%
Year-to-Date

Today’s Trading

Previous close43.58
Today’s open43.70
Day’s range43.62 - 44.56
Volume1,302,313
Average volume (3 months)1,712,920
Market cap$6.6B
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+18.76%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.00

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.87+1.44%
TAROTaro Pharmaceutical ...+3.36+2.47%
OPKOPKO Health Inc-0.11-1.04%
SGENSeattle Genetics Inc-0.68-1.69%
Data as of 05/26/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs